An official website of the United States government
Government Funding Lapse Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at opm.gov.
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Trial Status: active
The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of
the long-term safety and efficacy of pirtobrutinib after completion of clinical studies
evaluating pirtobrutinib. The clinical studies that will feed into this master protocol
are referred to as originator studies. The master protocol will govern individual
study-specific appendices (ISAs) that will represent participants from the individual,
completed originator studies. These participants will have the opportunity to enter this
study and continue to receive treatment or continue follow-up visits. Overall, the master
protocol and the individual ISAs, when combined, define the investigations for this
study.
Inclusion Criteria
Inclusion Criteria:
- Are participating in an eligible Lilly sponsored clinical study evaluating
pirtobrutinib.
Exclusion Criteria:
Exclusion criteria are defined in each ISA.
Additional locations may be listed on ClinicalTrials.gov for NCT06876649.
Locations matching your search criteria
United States
Florida
Miami
University of Miami Miller School of Medicine-Sylvester Cancer Center
Status: Active
Name Not Available
Georgia
Atlanta
Emory Saint Joseph's Hospital
Status: Active
Name Not Available
Emory University Hospital/Winship Cancer Institute
